These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1282015)

  • 21. Prevalence and clinical significance of zidovudine resistance mutations in human immunodeficiency virus isolated from patients after long-term zidovudine treatment. AIDS Clinical Trials Group 116B/117 Study Team and the Virology Committee Resistance Working Group.
    Japour AJ; Welles S; D'Aquila RT; Johnson VA; Richman DD; Coombs RW; Reichelderfer PS; Kahn JO; Crumpacker CS; Kuritzkes DR
    J Infect Dis; 1995 May; 171(5):1172-9. PubMed ID: 7538548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MT-2 tropism and CCR-5 genotype strongly influence disease progression in HIV-1-infected individuals.
    Bratt G; Leandersson AC; Albert J; Sandström E; Wahren B
    AIDS; 1998 May; 12(7):729-36. PubMed ID: 9619804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV phenotype switching during antiretroviral therapy: emergence of saquinavir-resistant strains with less cytopathogenicity.
    Ercoli L; Sarmati L; Nicastri E; Giannini G; Galluzzo C; Vella S; Andreoni M
    AIDS; 1997 Aug; 11(10):1211-7. PubMed ID: 9256938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotypic and genotypic resistance patterns of HIV-1 isolates derived from individuals treated with didanosine and stavudine.
    Coakley EP; Gillis JM; Hammer SM
    AIDS; 2000 Jan; 14(2):F9-15. PubMed ID: 10708277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human immunodeficiency virus type 1 phenotypes in children with advanced disease treated with long-term zalcitabine.
    Viani RM; Smith IL; Spector SA
    J Infect Dis; 1998 Mar; 177(3):565-70. PubMed ID: 9498433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 reverse transcriptase (RT) genotype and susceptibility to RT inhibitors during abacavir monotherapy and combination therapy.
    Miller V; Ait-Khaled M; Stone C; Griffin P; Mesogiti D; Cutrell A; Harrigan R; Staszewski S; Katlama C; Pearce G; Tisdale M
    AIDS; 2000 Jan; 14(2):163-71. PubMed ID: 10708287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transmission of zidovudine-resistant human immunodeficiency virus type 1 variants following deliberate injection of blood from a patient with AIDS: characteristics and natural history of the virus.
    Veenstra J; Schuurman R; Cornelissen M; van't Wout AB; Boucher CA; Schuitemaker H; Goudsmit J; Coutinho RA
    Clin Infect Dis; 1995 Sep; 21(3):556-60. PubMed ID: 8527543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Viral phenotype and T cell reactivity in human immunodeficiency virus type 1-infected asymptomatic men treated with zidovudine.
    Koot M; Schellekens PT; Mulder JW; Lange JM; Roos MT; Coutinho RA; Tersmette M; Miedema F
    J Infect Dis; 1993 Sep; 168(3):733-6. PubMed ID: 8102631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenicity and diversity of HIV and implications for clinical management: a review.
    Saag MS; Hammer SM; Lange JM
    J Acquir Immune Defic Syndr (1988); 1994; 7 Suppl 2():S2-10; discussion S10-1. PubMed ID: 7965648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reverse transcriptase mutations in sequential HIV-1 isolates in a patient with AIDS.
    Gurusinghe AD; Land SA; Birch C; McGavin C; Hooker DJ; Tachedjian G; Doherty R; Deacon NJ
    J Med Virol; 1995 Jul; 46(3):238-43. PubMed ID: 7561796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay.
    Koot M; Vos AH; Keet RP; de Goede RE; Dercksen MW; Terpstra FG; Coutinho RA; Miedema F; Tersmette M
    AIDS; 1992 Jan; 6(1):49-54. PubMed ID: 1543566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture.
    Schuitemaker H; Kootstra NA; de Goede RE; de Wolf F; Miedema F; Tersmette M
    J Virol; 1991 Jan; 65(1):356-63. PubMed ID: 1985204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization.
    De Wolf F; Hogervorst E; Goudsmit J; Fenyö EM; Rübsamen-Waigmann H; Holmes H; Galvao-Castro B; Karita E; Wasi C; Sempala SD
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1387-400. PubMed ID: 7888192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT).
    Larder BA; Kemp SD
    Science; 1989 Dec; 246(4934):1155-8. PubMed ID: 2479983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS clinical trials group protocol 315.ACTG Protocol 315 Team.
    Kuritzkes DR; Sevin A; Young B; Bakhtiari M; Wu H; St Clair M; Connick E; Landay A; Spritzler J; Kessler H; Lederman MM
    J Infect Dis; 2000 Feb; 181(2):491-7. PubMed ID: 10669331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations linked to drug resistance, human immunodeficiency virus type 1 biologic phenotype and their association with disease progression in children receiving nucleoside reverse transcriptase inhibitors.
    Englund JA; Raskino C; Vavro C; Palumbo P; Ross LL; McKinney R; Nikolic-Djokic D; Colgrove RC; Baker CJ;
    Pediatr Infect Dis J; 2004 Jan; 23(1):15-22. PubMed ID: 14743040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of antiviral effect owing to zidovudine and lamivudine double resistance in HIV-1-infected patients in an ongoing open-label trial.
    Rusconi S; De Pasquale MP; Milazzo L; Moscatelli G; Bulgheroni E; Citterio P; d'Arminio-Monforte A; Moroni M; Galli M
    Antivir Ther; 1997 Jan; 2(1):39-46. PubMed ID: 11322265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT).
    Dis Markers; 1990; 8(3):163-4. PubMed ID: 1703061
    [No Abstract]   [Full Text] [Related]  

  • 40. HIV-1 reverse transcriptase codon 215 mutation and clinical outcome in children treated with zidovudine.
    Principi N; Marchisio P; De Pasquale MP; Massironi E; Tornaghi R; Vago T
    AIDS Res Hum Retroviruses; 1994 Jun; 10(6):721-6. PubMed ID: 7521192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.